Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers detail new studies and findings in the area of breast cancer
December 15th, 2005
Breast cancer data are the focus of recent research from Finland, the Canada H2W 1S6; brian and Austria. Study 1: Cyclin A is a good marker for breast cancer tumor proliferation and prognosis. According to recent research from Finland, "We wanted to study cyclin A as a marker for prognosis and chemotherapy response. A total of 283 women with metastatic breast cancer were initially enrolled in a randomized multicenter trial comparing docetaxel to sequential methotrexate-fluorouracil (MF) in advanced breast cancer after anthracycline failure." "Paraffin-embedded blocks of the primary tumor were available for 96 patients (34%). The...
Source: Women's Health Weekly (2005-12-15)
|
